Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Miraisozo

Status
ACTIVE
Global HQ
Seoul, South Korea
Countries of investment
  • USA
Investment stages
  • Pre-Seed
  • Seed
Industries
  • Fintech
  • Blockchain
  • Crypto
  • AI
  • Data
About
Miraisozo is a venture Capital firm based in Japan, focusing on investing in early stage startups and innovative technologies. They aim to support high potential companies with Capital and strategic guidance to foster growth and success.
Min check size
$10K
Max check size
$1K
Fund size
NPS

Investment Thesis

Innovations and Future Creation Inc. (MIRAI SOUZOU) collaborates with entrepreneurs to challenge the supercritical boundaries of Technology and Business, creating extraordinary futures. They focus on research and development startups, especially those associated with Tokyo Institute of Technology.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

SiteOne Therapeutics

Alessa Therapeutics

Nuvig Therapeutics

Jupiter BioVentures

Velocity Bio

Babylon Biosciences

Umlaut.Bio

TippingPoint Biosciences

Cloverleaf Bio

NuCyRNA Therapeutics

March Biosciences

Vaxess Technologies

Mediar Therapeutics

AmbAgon Therapeutics

Asher Bio

Bolt

Alector

Effector Therapeutics

Pionyr Immunotherapeutics

Caribou Biosciences

True North Therapeutics

Vedere Bio

Pandion Therapeutics

Mitokinin

Zymergen

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp